Prevalence and risk factors of hearing loss in children with solid tumors treated with platinum-based chemotherapy

Journal Title: Paediatrica Indonesiana - Year 2015, Vol 55, Issue 3

Abstract

Background The platinum-based chemotherapy drugs, cisplatin and carboplatin, are widely used in the treatment of several types of solid tumors. However, the treatment has side effects including hearing loss.Objective To evaluate the prevalence of hearing loss related to platinum-based chemotherapy and to identify associated factors.Methods A cross-sectional study was performed in Adam Malik Hospital, Medan, North Sumatera, from April to July 2012. Twenty-two subjects who fulfilled the eligibility criteria underwent otoacoustic emission evaluations. Eleven children had received cisplatin and eleven had received carboplatin. The association between hearing loss and risk factors was assessed using Fisher’s exact and Chi-square tests.Results Seven subjects with hearing loss were identified. Five of these patients (5 out of 11) had received cisplatin and 2 patients (2 out of 11) had received carboplatin. There was no statistically significant difference between carboplatin- and cisplatin-associated hearing loss (P=0.361). Neither gender (P=0.452) nor age (P=0.212) was related to hearing loss. However, higher cumulative chemotherapy doses (cisplatin >600 mg/m² and carboplatin >1800 mg/m²) were associated with hearing loss (P=0.022 and P=0.004, respectively).Conclusion Patients who had higher cumulative doses of platinum-based chemotherapy are at risk for developing hearing loss.

Authors and Affiliations

Eka D Edward, Nelly Rosdiana, Farhat Farhat, Olga Siregar, Bidasari Lubis

Keywords

Related Articles

Selenium and functional constipation in children

Background Constipation is a common problem in children, with approximately 90 to 95% of constipation cases having functional constipation. Oxidative stress may be a causative factor in gastrointestinal diseases, alleved...

Transcutaneous billirubinometry to estimate total serum bilirubin in neonatal jaundice

Background The gold standard for diagnosis of neonatal jaundice is total serum bilirubin (TSB) measurement. This method, however, is invasive, painful, and costly in terms of workload, time, and money. Moreover, repeated...

The outcomes of childhood acute lymphoblastic leukemia with hyperleukocytosis

Background Hyperleukocytosis in childhood acute lymphoblastic leukemia (ALL) is an  emergency in oncology. This condition showed high mortality and relapse rates, as well as low survival rate. The outcomes of this g...

Consumption of energy-dense, nutrient-poor foods and hypertension in obese children

Background Obesity has become an increasingly important medicalproblem in children. Obesity-induced hypertension in childhoodshould be considered as a chronic medical condition that is likelyto require long-term manageme...

Linear growth patterns in small for gestational age and preterm infants after zinc supplementation

Background Low birth weight (LBW) infants are at risk for growth disturbances due to intrauterine zinc deficiency. Zinc supplementation is expected to improve the linear growth of LBW babies. Objective To assess the effe...

Download PDF file
  • EP ID EP448536
  • DOI 10.14238/pi55.3.2015.121-5
  • Views 41
  • Downloads 0

How To Cite

Eka D Edward, Nelly Rosdiana, Farhat Farhat, Olga Siregar, Bidasari Lubis (2015). Prevalence and risk factors of hearing loss in children with solid tumors treated with platinum-based chemotherapy. Paediatrica Indonesiana, 55(3), 121-5. https://europub.co.uk/articles/-A-448536